Galderma
Also known as: Galderma | Galderma Brasil Lltda | Galderma Brasil Ltda. | Galderma Canada | Galderma investigational center | Galderma Laboratories | Galderma Laboratories, LP | Galderma Laboratories, L.P. | Galderma Laboratorium GmbH | GALDERMA LABS | GALDERMA LABS LP | GALDERMA R AND D | Galderma R&D | Galderma R&D, Inc | Galderma R&D, Inc. | Galderma R&D, LLC
Highest phase reached
Phase 4
First clinical trial
Sep 30, 2000First marketed drug
Dec 14, 1984First NDA
May 31, 1996Last known activity
Dec 15, 2025
Timeline
1980s
- Jan 1, 1981
Galderma— Founded
1990s
- May 31, 1996
adapalene— NDA Organization
2000s
- Jan 18, 2002
tretinoin— Marketing Organization
- Apr 11, 2008
CollaGenex Pharmaceuticals— Acquired
2010s
- Jan 5, 2011
Q-Med AB— Acquired
- Dec 1, 2012
Spirig Pharma Ltd.— Acquired
- Aug 23, 2013
brimonidine— NDA Secondary Org
- Feb 11, 2014
Nestle— Acquired By
Drugs by trial phase (53 distinct, 195 trials)
Phase 4 (33 own, 5 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (5 own, 2 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Approved for
Studied for
- Acne Vulgaris
- Atrophy
- Blepharitis
- Congenital Abnormalities
- Dermatitis
- Dermatitis, Atopic
- Dermatitis, Seborrheic
- Eczema
- Erythema
- Facies
- Flushing
- Foot Dermatoses
- Hypersensitivity
- Inflammation
- Keratosis
- Keratosis, Actinic
- Lentigo
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Melanosis
- Neurodermatitis
- Onychomycosis
- Prurigo
- Psoriasis
- Purpura
- Rosacea
- Skin Diseases
- Skin Manifestations
- Skin Ulcer
- Striae Distensae
- Vascular Malformations
Marketed drugs (16)
Subsidiaries (3 direct, 3 total across the full acquisition tree)
Recent trials (50)
- NCT07047690Lead sponsorPhase 2Dec 15, 2025
- NCT07225348CollaboratorPhase 4Nov 3, 2025
- NCT07074977Lead sponsorPhase 2Sep 30, 2025
- NCT07186413Lead sponsorPhase 3Sep 23, 2025
- NCT06357221Lead sponsorPhase 4Apr 8, 2024
- NCT06015217Lead sponsorPhase 4Aug 25, 2023
- NCT05686928Lead sponsorPhase 4Aug 17, 2022
- NCT05405985Lead sponsorPhase 1Aug 11, 2022
- NCT05463965Lead sponsorPhase 3Jul 29, 2022
- NCT05277337Lead sponsorPhase 4Feb 4, 2022
- NCT05052983Lead sponsorPhase 3Jan 31, 2022
- NCT05056779Lead sponsorPhase 3Jan 31, 2022
- NCT05089708Lead sponsorPhase 4Dec 31, 2021
- NCT05075408Lead sponsorPhase 2/Phase 3Dec 31, 2021
- NCT04921345Lead sponsorPhase 2Jun 24, 2021
Details
- Founded
- Lausanne, CH Jan 1, 1981
- First NDA
- May 31, 1996
- Last known activity
- Dec 15, 2025
Designations held
- Priority review
Notes
Acquired by Nestle in 2014